Intensive insider selling can be defined by the following three criteria:
The stock was sold by three or more insiders within one month.
The stock was not purchased by any insiders in the month of intensive selling.
At least two sellers decreased their holdings by more than 10%.
There was intensive insider selling in Johnson & Johnson again in July/August this year. This was the first time since November 2011, that Johnson & Johnson saw intensive insider selling. Three different insiders decreased their holdings by more than 10%:
Michael Ullmann sold 16,140 shares on August 5, and currently holds 55,427 shares or less than 0.1% of the company. Michael Ullmann is Vice President, General Counsel of Johnson & Johnson and a member of the Executive Committee.
Paulus Stoffels sold 45,440 shares on July 25, and currently holds 16,801 shares or less than 0.1% of the company. Paulus Stoffels is the Chief Scientific Officer, Johnson & Johnson, and Worldwide Chairman, Pharmaceuticals.
Dominic Caruso sold 30,000 shares on July 18, and currently holds 53,534 shares or less than 0.1% of the company. Dominic Caruso is Vice President, Finance and Chief Financial Officer of Johnson & Johnson.
Here is a table of Johnson & Johnson's insider-trading activity by calendar month.
Month Insider selling / shares Insider buying / shares
August 2013 16,140 0
July 2013 75,440 0
June 2013 0 0
May 2013 4,929 0
April 2013 0 0
March 2013 0 0
February 2013 0 0
January 2013 0 0
There have been 96,509 shares sold and there have been zero shares purchased by the insiders this year.